Plus Therapeutics, Inc. (PSTV)
NASDAQ: PSTV · IEX Real-Time Price · USD
1.630
-0.080 (-4.68%)
At close: Apr 19, 2024, 3:59 PM
1.650
+0.020 (1.23%)
After-hours: Apr 19, 2024, 5:58 PM EDT
Plus Therapeutics Stock Forecast
PSTV's stock price has decreased by -61.61% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Plus Therapeutics stock have an average target of 10, with a low estimate of 8.00 and a high estimate of 12. The average target predicts an increase of 513.50% from the current stock price of 1.63.
Analyst Consensus: Strong Buy
* Price targets were last updated on Aug 15, 2023.
Analyst Ratings
The average analyst rating for PSTV stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $8 | Strong Buy | Reiterates | $8 | +390.80% | Aug 15, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $8 | Strong Buy | Reiterates | $8 | +390.80% | Aug 14, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $3.5 → $8 | Strong Buy | Maintains | $3.5 → $8 | +390.80% | Jun 30, 2023 |
| Maxim Group | Maxim Group | Strong Buy Maintains $30 → $12 | Strong Buy | Maintains | $30 → $12 | +636.20% | May 3, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $53 | Strong Buy | Reiterates | $53 | +3,120.86% | Apr 21, 2023 |
Financial Forecast
Revenue This Year
5.19M
from 4.91M
Increased by 5.54%
Revenue Next Year
2.92M
from 5.19M
Decreased by -43.61%
EPS This Year
-2.46
from -4.24
EPS Next Year
-2.44
from -2.46
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 8.9M | 5.3M | n/a | 57.0M | 91.6M |
| Avg | 5.2M | 2.9M | n/a | 31.7M | 68.2M |
| Low | n/a | n/a | n/a | 7.7M | 45.5M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 80.6% | 1.3% | - | - | 189.0% |
| Avg | 5.5% | -43.6% | - | - | 115.1% |
| Low | - | - | - | - | 43.6% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -1.85 | -1.62 | -1.72 | -0.56 | 0.12 |
| Avg | -2.46 | -2.44 | -2.73 | -1.14 | 0.09 |
| Low | -2.76 | -3.02 | -3.64 | -1.68 | 0.06 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.